Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study.

Front Oncol · 2023 · PMC10312386 · PMID 37397389

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Additionally, while there was an overall trend towards improved survival across all stages, patients with metastatic disease at diagnosis (n=80) did not exhibit any difference in survival with metformin exposure, though this was relatively small cohort.

also in 1,675 other papers

did not reach statistical significanceno p-value reported

OS was numerically increased in nearly all stages exposed to metformin, though this did not reach statistical significance.

also in 34,328 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.